Silo Pharma, Inc.
SILO
$1.02
-$0.0225-2.16%
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 18.00K | 18.00K | 18.00K | 18.00K | 18.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.00K | 18.00K | 18.00K | 18.00K | 18.00K |
| Cost of Revenue | 1.50K | 1.50K | 1.50K | 1.50K | 1.50K |
| Gross Profit | 16.60K | 16.60K | 16.60K | 16.60K | 16.60K |
| SG&A Expenses | 615.50K | 1.00M | 617.10K | 1.04M | 589.90K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 791.40K | 1.13M | 821.50K | 1.68M | 967.20K |
| Operating Income | -773.40K | -1.12M | -803.50K | -1.66M | -949.20K |
| Income Before Tax | -660.20K | -1.01M | -906.40K | -1.66M | -983.20K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -660.20K | -1.01M | -906.40K | -1.66M | -983.20K |
| Earnings from Discontinued Operations | -- | -- | -- | 0.00 | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -660.20K | -1.01M | -906.40K | -1.66M | -983.20K |
| EBIT | -773.40K | -1.12M | -803.50K | -1.66M | -949.20K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.21 | -0.32 | -0.29 | -0.52 | -0.49 |
| Normalized Basic EPS | -0.13 | -0.20 | -0.15 | -0.31 | -0.30 |
| EPS Diluted | -0.21 | -0.32 | -0.29 | -0.52 | -0.49 |
| Normalized Diluted EPS | -0.13 | -0.20 | -0.15 | -0.31 | -0.30 |
| Average Basic Shares Outstanding | 3.11M | 3.15M | 3.16M | 3.18M | 2.00M |
| Average Diluted Shares Outstanding | 3.11M | 3.15M | 3.16M | 3.18M | 2.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
